Physician

Sreenadha Reddy Vattam, MD

According to 2025 Medicare claims, Sreenadha Vattam, MD (NPI: 1427082171) practices pain management in the Sherman-Denison, TX market, with the plurality of this provider's patient population coming from Grayson, TX. This provider's primary affiliated billing organization is DALLAS PAIN INSTITUTE (NPI: 1194308601; TIN: 861315797) and primary practice location at 75088-4362.

Vattam's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 540 traditional Medicare patients, billed 13,047 HCPCS/CPT codes, and received $776,610 in Medicare payments. The top billing code was G0480 (Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms). Part D data shows 4,941 prescription claims across 770 beneficiaries totaling $184,170 in drug costs, led by Hydrocodone-Acetaminophen (Hydrocodone/Acetaminophen). DME data shows 71 claims. Open Payments data shows 50 records totaling $1,862. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing did not follow a clear longitudinal pattern. Concurrently, Part D prescription costs have moved up and down with repeated peaks and valleys, starting at $219,463 and ending at $184,170. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$388K$777K2015 Medicare payment: $506,437 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $525,635 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $488,899 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $410,712 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $411,535 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $311,366 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $317,734 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $282,947 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $559,615 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $776,610 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
201551812,949$506,437
20166188,361$525,635
201759410,085$488,899
20185128,983$410,712
20194857,587$411,535
20204136,454$311,366
20214356,051$317,734
20224524,851$282,947
20235349,399$559,615
202454013,047$776,610

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$389K$779K2015 Drug cost: $219,463 (USD; Tot_Drug_Cst)2016 Drug cost: $662,365 (USD; Tot_Drug_Cst)2017 Drug cost: $778,617 (USD; Tot_Drug_Cst)2018 Drug cost: $539,492 (USD; Tot_Drug_Cst)2019 Drug cost: $260,872 (USD; Tot_Drug_Cst)2020 Drug cost: $150,110 (USD; Tot_Drug_Cst)2021 Drug cost: $133,253 (USD; Tot_Drug_Cst)2022 Drug cost: $183,411 (USD; Tot_Drug_Cst)2023 Drug cost: $195,154 (USD; Tot_Drug_Cst)2024 Drug cost: $184,170 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
20153482,848$219,463
20164914,491$662,365
20175446,241$778,617
20184615,407$539,492
20194644,026$260,872
20204513,815$150,110
20215113,278$133,253
20226144,909$183,411
20237264,810$195,154
20247704,941$184,170

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

DME Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: DME_Suplr_Mdcr_Pymt_Amt. Source: Medicare DME, Devices & Supplies by Referring Provider.0$24K$47K2024 Medicare payment: $47,292 (USD; DME_Suplr_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClaimsPayment
2015N/RN/RN/R
2016N/RN/RN/R
2017N/RN/RN/R
2018N/RN/RN/R
2019N/RN/RN/R
2020N/RN/RN/R
2021N/RN/RN/R
2022N/RN/RN/R
2023N/RN/RN/R
20247171$47,292

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
G0480Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms318740$111
99214Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more4512,281$86
99213Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more192460$66
80307Testing for presence of drug, by chemistry analyzers4541,143$60
99484Care management services for behavioral health conditions, 20 minutes or more clinical staff time directed by health care professional4691,835$38

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen3,11290,607$90,689
Xtampza ErOxycodone Myristate32960$37,156
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen50814,988$13,533
Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl581,651$11,749
Oxycodone HclOxycodone Hcl2858,356$5,035

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS CodeHCPCS DescriptionSupplier Rental IndicatorTotal Supplier BeneficiariesTotal Supplier ClaimsTotal Medicare Payment Amount
L0651Lumbar-sacral orthosis, sagittal-coronal control, rigid shell(s)/panel(s), posterior extends from sacrococcygeal junction to t-9 vertebra, anterior extends from symphysis pubis to xyphoid, produces intracavitary pressure to reduce load on the intervertebral discs, overall strength is provided by overlapping rigid material and stabilizing closures, includes straps, closures, may include soft interface, pendulous abdomen design, prefabricated, off-the-shelfN7171$47,292

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.50$1,862Boston Scientific Corporation
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Sreenadha Reddy Vattam, MD?

Tedicare shows public-source Medicare data for Sreenadha Reddy Vattam, MD (NPI 1427082171), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Sreenadha Reddy Vattam, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Sreenadha Reddy Vattam, MD?

Sreenadha Reddy Vattam, MD is linked to DALLAS PAIN INSTITUTE (billing NPI 1194308601) in the available physician profile data.

Does Sreenadha Reddy Vattam, MD have Open Payments data?

Sreenadha Reddy Vattam, MD has 50 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.